Satlin A, Wang J, Logovinsky V, Berry S, Swanson C, Dhadda S, Berry DA.
Design of a Bayesian adaptive phase 2 proof-of-concept trial for BAN2401, a putative disease-modifying monoclonal antibody for the treatment of Alzheimer's disease.
Alzheimers Dement (N Y). 2016 Jan;2(1):1-12. Epub 2016 Feb 4